About Intraperitoneal (IP) Chemotherapy Memorial Sloan Kettering Cancer Center

This information explains what intraperitoneal (IP) chemotherapy is and how to get ready for it.

Memorial Sloan Kettering Curbs Executives' Ties to Industry After Conflict-of-Interest Scandals — ProPublica

About Intraperitoneal (IP) Chemotherapy Memorial Sloan Kettering Cancer Center

Types of Cancer Treatments: Chemotherapy at MSK

Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer.

Dr. Nai-Kong Cheung, MD, New York, NY

JCM, Free Full-Text

PPT - Investigating the Role of Anti-Angiogenic Agents in Ovarian Cancer PowerPoint Presentation - ID:414923

Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancer. - Abstract - Europe PMC

Yonina Bykov's research works Memorial Sloan Kettering Cancer

PDF) Doublet Chemotherapy in the Elderly Patient With Ovarian Cancer

Hyperthermic intraperitoneal chemotherapy (HIPEC) after primary

Beryl Manning-Geist, MD - Gynecologic Oncology Fellow - Memorial Sloan Kettering Cancer Center

PDF) Intraperitoneal chemotherapy for epithelial ovarian carcinoma

Intraperitoneal Chemotherapy as a Multimodal Treatment for Gastric